The Alliance for Regenerative Medicine’s annual Cell & Gene State of the Industry Briefing is a top-level gathering for key stakeholders in the field. This event includes ARM’s annual yearly update on the sector’s progress and two noteworthy sessions featuring top CEOs and executives highlighting future inflection points for cell and gene therapies in the coming year.
Nearly 2,000 of the cell and gene therapy field’s top stakeholders attend – both in-person and virtually – including company founders, C-level business executives, investors, media, patient advocates and academic leaders interested in learning more on the sector’s recent advances and outlook for the industry in the coming year.
Tim Hunt, CEO, Alliance for Regenerative Medicine
Download PPT Slides
Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration (FDA)
Whitney Ijem, Managing Director and Senior Biotechnology Analyst, Canaccord Genuity (Moderator)
Jim Birchenough, M.D., Chairman and Global Co-Head, Barclays Biopharmaceutical Investment Banking
Keith Crandell, Co-founder and Managing Director, ARCH Venture Partners
Lynelle Hoch, President, Cell Therapy Organization, Bristol Myers Squibb
Kinnari Patel, Pharm.D., President, Head of R&D and Chief Operating Officer, Rocket Pharma
Biotech Showcase is a premier investor conference committed to creating a platform for private and micro-mid-cap biotechnology companies, offering them a unique opportunity to showcase their innovations and engage one-to-one with investors and biopharmaceutical executives. ARM members will receive a $200 discount off their Biotech Showcase registration fees when they use the VIP code: ARM200
333 O'Farrell St.
San Francisco, CA 94102
